Brief History
Over half a century since the foundation in 1968, Samjin Pharm has solidified its position by keeping the dignity of the pharmaceutical industry.
2020’s - 2011’s
Strived for the R&D of new drugs
2020
2011
-
2020.10
Digital healthcare startup 'Wellysis' business collaboration & investment agreement, entering into medical device business -
2020.07
Open the official online store 'Market On J' and launch the healthcare brand 'Wish Healthy' -
2020.04
R&D collaboration contract with Standigm to develop novel anti-cancer drugs using Artificial Intelligence-based drug discovery platform -
2019.04
R&D collaboration contract with Korea Research Institute of Chemical Technology to develop novel targeted therapy of cancer and immunotherapy of cancer. -
2019.03
Chang Hong Soon and Choi Yong Joo inaugurated for C.E.O and chairman -
2018.09
R&D collaboration contract with AptaBio to develop novel therapeutics for the treatment of age-related macular degeneration -
2017.12
R&D collaboration contract with Dept. of Pharmacy in Hanyang University to develop novel therapeutics for the treatment of Alzheimer’s disease -
2017.09
Approval of clinical phase 2 by KFDA for oral xeroma treatment drug -
2017.02
R&D collaboration contract with Korea Research Institute of Bioscience and Biotechnology to develop novel therapeutics for the treatment of Alzheimer’s disease and diabetes. -
2016.06
R&D collaboration contract with Institut Pasteur Korea to develop novel therapeutics for the treatment of hepatocellular carcinoma. -
2016.03
R&D collaboration contract with APTA Bio to develop novel targeted therapy of cancer -
2015.12
R&D collaboration contract with Bioinformatics and Molecular Design Research Center to develop novel drugs -
2015.06
Advancement of 10 raw materials of antithrombotic and other items and drug preparation techniques to Indonesia -
2015.04
Approval of IND by KFDA for oral xeroma treatment -
2014.10
Opened quality centers of Samjin Pharmaceuticals -
2014.10
The governmental support for the development of a new drug ‘SA001‘ the oral xeroma treatment -
2014.07
Approval of IND of Samjin Pharmaceuticals, the AIDS prevention drug for females by the US FDA -
2013.09
Opening ceremony of Central Research Institute in Pangyo Techno Valley complex -
2013.03
Completion of C.G.M.P Osong plant -
2012.06
Selected as innovative pharmaceutical company
2010’s - 2001’s
Soaring through innovation and change
2010
2001
-
2010.11
Awarded the $ 3.0 million export trophy (47th trade day) -
2008.11
Introduction of retirement pension -
2007.02
Influenza & Hepatitis B Treatment New materials Patent application -
2006.09
SARS bacteria New coronavirus Treatment New materials Patent application -
2006.02
Hepatitis C Treatment New materials Patent application -
2005.05
Project of research and development of cell application was selected by Ministry of Science and Technology -
2005.01
Completion of office building of headquarters and moving in -
2004.02
Awarded the Grand prize in the 16th [fruitful company] selected by Korea employers federation -
2003.07
Started the construction of new office building of headquarters -
2001.11
Awarded the $ 1.0 million export trophy (38th trade day) -
2001.09
President Lee, Sung Woo was appointed
2000’s - 1991’s
Dreaming of new initiatives and jumps
2000
1991
-
1999.
“Geborin” was selected as the most preferred analgesic agent by customers on the 'Consumer News' -
1999.07
Acquired American patent of medicine for AIDS and Y2K certification (Korea Management Association) -
1998.12
Selected as one of top 10 companies by Hanmi Bank -
1997.07
Awarded Silver Tower Industry Medal (Sector of Small and medium enterprises No. 502) -
1996.05
Awarded the Steel Tower Decoration of Industrial Service Merit (Sector of labor management relation NO. 1179) -
1996.01
International patent application for a remedy for solid tumor (Korea and 45 other countries) -
1993.05
International patent application for a new analgesic anti- inflammatory agent (9 countries)
1990’s - 1981’s
Establishing a solid foothold in the
pharmaceutical industry
1990
1981
-
1988.10
Completion of a man-less automation warehouse -
1988.05
A public opening of stocks (IPO shares, capital of 3 billion won at the time) -
1987.03
Designated as place appropriate for K.G.M.P qualification (Ministry of Health and society NO. 19) -
1986.12
Central Research laboratories designated as exemption for the military service (NO. 770) -
1985.11
Completion of K.G.M.P Hyangnam plant -
1985.06
Established and authorized the affiliated central research laboratory (Ministry of Science and Technology) -
1985.03
Received the award from President (sector of exemplary industrialist/NO. 62408) -
1984.10
Awarded ('84) grand prize in productivity -
1984.03
Established Korean Federation of Community Credit -
1983.03
Received the recognition from the Minister of Finance (sector in an exemplary taxpayer)
1980’s - 1968’s
Take the first step forward for Samjin
1980
1968
-
1977.12
Implementation of Samjin Gold Prize System (sectors of Creation, pioneering and Advance) -
1977.03
Implementation of a five day working system -
1976.07
Launching Samjin Scholarship foundation -
1972.11
Acquired DaeHan Changgi Pharm Co., Ltd and renamed to Samjin Pharm Co., Ltd -
1970.12
Established Samjin trading company (Wholesaler for pharmaceutical products, license No. 12)